We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+2.85%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$5.52B
AUM Growth
-$2.44B
Cap. Flow
-$2.44B
Cap. Flow %
-44.19%
Top 10 Hldgs %
51.97%
Holding
165
New
38
Increased
22
Reduced
40
Closed
65

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$420M
2
TRP icon
TC Energy
TRP
+$318M
3
CF icon
CF Industries
CF
+$203M
4
BABA icon
Alibaba
BABA
+$129M
5
PXD
Pioneer Natural Resource Co.
PXD
+$129M

Sector Composition

Rank Sector Weight
1 Healthcare 28.63%
2 Energy 26.23%
3 Materials 9.07%
4 Consumer Discretionary 7.49%
5 Technology 6.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIG icon
26
Signet Jewelers
SIG
$3.84B
$49.7M 0.9%
436,000
+340,800
+358% +$37.7M
PPG icon
27
PPG Industries
PPG
$24.9B
$49.6M 0.9%
504,600
+216,000
+75% +$22M
MDCO
28
DELISTED
Medicines Co
MDCO
$45.5M 0.83%
2,040,584
-1,427,730
-41% -$36.3M
VLO icon
29
Valero Energy
VLO
$89.5B
$45.5M 0.83%
984,074
-4,841,900
-83% -$244M
DG icon
30
Dollar General
DG
$28.4B
$41.3M 0.75%
676,300
+526,100
+350% +$31.5M
DHR icon
31
Danaher
DHR
$138B
$40.1M 0.73%
+784,683
New +$40.3M
RICE
32
DELISTED
Rice Energy Inc.
RICE
$38.9M 0.71%
+1,464,000
New +$40.9M
SEE
33
DELISTED
Sealed Air
SEE
$37.8M 0.69%
+1,083,300
New +$37.5M
ZLTQ
34
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$36.2M 0.66%
1,597,900
-67,100
-4% -$1.33M
DAL icon
35
Delta Air Lines
DAL
$56.7B
$36M 0.65%
996,700
-1,965,300
-66% -$75.1M
A icon
36
Agilent Technologies
A
$39.6B
$34.8M 0.63%
+854,458
New +$34.9M
AGN
37
DELISTED
Allergan plc
AGN
$33.1M 0.6%
137,000
+134,200
+4,793% +$30M
BKD icon
38
Brookdale Senior Living
BKD
$3.55B
$32.2M 0.58%
1,000,000
+700,000
+233% +$23.9M
YHOO
39
DELISTED
Yahoo Inc
YHOO
$31.6M 0.57%
+775,900
New +$29.1M
WNR
40
DELISTED
Western Refining Inc
WNR
$31M 0.56%
737,500
-327,300
-31% -$14.1M
APD icon
41
Air Products & Chemicals
APD
$65.5B
$30.6M 0.55%
+254,143
New +$31.1M
QQQ icon
42
PUT
Invesco QQQ Trust
QQQ
$436B
$29.6M 0.54%
+299,300
New +$29.2M
WMGI
43
DELISTED
Wright Medical Group Inc
WMGI
$27.3M 0.49%
900,000
-25,000
-3% -$770K
GNC
44
DELISTED
GNC Holdings, Inc.
GNC
$27.1M 0.49%
+700,000
New +$25.4M
RCPT
45
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$24.8M 0.45%
+400,000
New +$19.1M
LUMO
46
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$24.1M 0.44%
125,000
+36,111
+41% +$7.94M
HD icon
47
Home Depot
HD
$337B
$22.9M 0.42%
+250,000
New +$21.4M
HSP
48
DELISTED
HOSPIRA INC
HSP
$20.8M 0.38%
400,000
-400,000
-50% -$21.2M
NPSP
49
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$20.8M 0.38%
800,000
-50,000
-6% -$1.44M
ARIA
50
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$20.3M 0.37%
3,750,000
+1,800,000
+92% +$10.5M

Similar funds

PointState Capital's Q3 2014 Portfolio in Review

As of Q3 2014, PointState Capital held 165 positions worth $5.52B, down 31% from $7.96B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

PointState Capital withdrew a net $2.44B in Q3 2014, closing 65 positions and reducing 40 holdings. Its most notable exit was Paramount Global Class B, an estimated $504M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Energy and Materials.

Against the trend, PointState Capital opened a new position in AbbVie worth $437M.

  • PointState Capital's largest Q3 2014 buy was AbbVie: 7,568,600 shares worth $437M.
  • PointState Capital added most to CF Industries in Q3 2014, an estimated $203M increase.
  • PointState Capital's biggest Q3 2014 reduction was Walgreens Boots Alliance, cutting an estimated $478M.
  • PointState Capital fully exited Paramount Global Class B in Q3 2014, selling an estimated $504M.
  • PointState Capital's ten largest holdings make up 52% of its $5.52B portfolio in Q3 2014.
  • PointState Capital opened 38 new positions and closed 65 in Q3 2014.
  • PointState Capital's portfolio value fell 31% quarter-over-quarter to $5.52B.

Based on PointState Capital's 13F filing for Q3 2014, filed 14 Nov 2014.